FDA approves breast specimen tomosynthesis system from Kubtec

The FDA has approved the first breast specimen radiography system with tomosynthesis technology, MOZART with TomoSpec, from Connecticut-based manufacturer Kubtec.

The specimen radiography system is designed to offer comprehensive analysis of excised breast tissue to help reduce re-excision and patient call-back rates, according to the company. MOZART performs 3D margin assessment in one step without turning or repositioning the specimen container.

MOZART with TomoSpec is a mobile system that connects wirelessly to PACS.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Trimed Popup
Trimed Popup